Difference of Bioseparation from
Chemical Separation
very
low concentrations
, bioseparation
has to be very selective in
nature.
. Injectable
therapeutic products should be free from endotoxins
and pyrogens.
susceptible to denaturation
thermolabile sub-ambient temperatures.
ulti-technique
separation.
• Biological products are separated based on the factors of:
Size: e.g. filtration, membrane separation, centrifugation
Density: e.g. centrifugation, sedimentation, floatation
Diffusivity: e.g. membrane separation
Shape: e.g.
centrifugation, filtration,
sedimentation
• Biological products are separated based on the factors of:
Polarity: e.g. extraction, chromatography, adsorption
Solubility: e.g. extraction, precipitation, crystallization
Electrostatic charge: e.g. adsorption, membrane separation, electrophoresis
Volatility:
e.g. distillation, membrane distillation, pervaporation
Physical
forms separated in bioseparation
Particle-liquid separation
e.g.
cells from cell culture medium
separation
method: filtration, centrifugation,
Particle-particle
separation in liquid medium
e.g.
fractionation of sub-cellular organelle, the separation of plasmid DNA from
chromosomal DNA
separation
method: zonal centrifugation
Particle-solute separation in liquid
medium
e.g.
dissolved
antibiotics from cells
separation
method: similar to particle-liquid separation
Physical
forms separated in bioseparation
Solute-solvent separation
e.g.
protein
concentration enrichment, solvent exchange
separation
method: membranes, adsorption, precipitation of solute
Solute-solute separation in liquid
medium
e.g.
serum albumin from
other serum proteins
separation
method: adsorption, extraction, precipitation, membranes
Liquid-liquid separation
e.g.
Acetone-ethanol
separation
method: distillation, phase separation
The RIPP scheme
(Removal of solids/insolubles, Isolation,
Purification, Polishing)
In RIPP scheme, these factors should be
taken into consideration:
• The
nature of starting material: e.g. a cell suspension, a crude protein solution
• The initial
location of the target product: e.g. intracellular, extracellular,
embedded in solid material such as inclusion bodies
• The volume
or flow-rate of the starting material
• The relative
abundance of the product in the starting material, i.e. its
concentration relative to impurities
• The
susceptibility to degradation e.g. its pH stability, sensitivity to high shear
rates or exposure to organic solvents
• The
desired physical form of the final product, e.g. Lyophilized powder, sterile solution, suspension
• The quality
requirements, e.g. percentage purity, absence of endotoxins or aggregates
• Process
costing and economics
The RIPP scheme
• Removal of solids/insolubles
– Filtration, centrifugation, microfiltration
• Isolation
of product (volume reduction)
– Cell disruption, extraction,
adsorption, ultrafiltration, precipitation
• Purification
– Adsorption, elution chromatography, ultrafiltration, electrophoresis, precipitation, crystallization
• Polishing
–
Crystallization, drying, auxiliary process, solvent recovery, water removal
The main
disadvantages of using the RIPP scheme are:
• High capital cost
• High operations cost
• Lower
recovery of product
A good bioseparation process:
• ensures desired
purity of product
• ensures stability of product
• keeps cost low as related to yield
• is reproducible
• is scalable
• meets regulatory guidelines
GLP and cGMP
GLP refers
to “good laboratory practice,” and cGMP refers to “current good
manufacturing
practice.”